Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022.
J Korean Med Sci
; 38(19): e143, 2023 May 15.
Article
in English
| MEDLINE | ID: covidwho-2318011
ABSTRACT
We conducted a cohort study to assess vaccine effectiveness (VE) of coronavirus disease 2019 vaccine combinations on severe acute respiratory syndrome coronavirus 2 critical infection and death among elderly population in Korea. From January to August 2022, VE against death for 4 doses mRNA recipients was 96.1%, whereas 1-dose viral vector + 3-dose mRNA recipients had VE of 90.8%.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Aged
/
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
J Korean Med Sci
Journal subject:
Medicine
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS